NL-OMON30455撤回4 期
Metformin, a weightreducing drug in the obese pediatric population? - Metformin, as a weightreducing drug.
Máxima Medisch Centrum0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 撤回
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 12 至 17（—）
入选标准
- •Age 10-18 years
排除标准
- •Diabetes mellitus
研究者
相似试验
已完成
不适用
Metformin and weight gain in the obese with pregnancyPACTR201505001142202Department of Obstetrics and Gynaecology200
已完成
3 期
Metformin for control of weight gain related to sodium valproate administration in adultsAssociation of metformin and control of weight gain related to sodium valproate administration in adults.Unspecified mental disorderIRCT2017071322991N8Vice chancellor for research of Babol University of Medical Sciences50
已完成
2 期
Metabolic modulation with metformin to reduce heart failure after acute myocardial infarction: Glycometabolic Intervention as adjunct to Primary percutaneous coronary intervention in ST elevation myocardial infarction (GIPS-III)Heart FailureNL-OMON39113niversitair Medisch Centrum Groningen380
进行中（未招募）
不适用
Metabolic modulation with metformin to reduce heart failure after acute myocardial infarction: Glycometabolic Intervention as adjunct to Primary percutaneous coronary intervention in ST elevation myocardial (GIPS-III) - GIPS-IIIpreservation and remodeling of the left ventricles after acute myocardial infarctionEUCTR2009-018162-34-NLThorax Center, Univeristy Medical Center Groningen, Groningen, The Netherlands
尚未招募
1 期
Metabolism Prescription Combined with Metformin in the Intervention of Type 2 Diabetes Mellitus Combined with Obesity: a Multicenter Randomized Controlled Double-Blind Clinical StudyType 2 Diabetes Mellitus combined with ObesityITMCTR2000003636onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine